These tools will no longer be maintained as of December 31, 2024. Archived website can be found here. PubMed4Hh GitHub repository can be found here. Contact NLM Customer Service if you have questions.


BIOMARKERS

Molecular Biopsy of Human Tumors

- a resource for Precision Medicine *

228 related articles for article (PubMed ID: 32960044)

  • 1.
    Lyerly DM; Boone JH; Carman RJ; Tillotson GS
    ACS Infect Dis; 2020 Nov; 6(11):2818-2829. PubMed ID: 32960044
    [No Abstract]   [Full Text] [Related]  

  • 2. Community-Associated Clostridioides difficile Infection in Children: A Review of Recent Literature.
    Adams DJ; Barone JB; Nylund CM
    J Pediatric Infect Dis Soc; 2021 Nov; 10(Supplement_3):S22-S26. PubMed ID: 34791398
    [TBL] [Abstract][Full Text] [Related]  

  • 3. Diagnosis and treatment of Clostridioides difficile infection.
    Mateu L; Fernández-Rivas G; Sopena N
    Med Clin (Barc); 2020 Jul; 155(1):30-35. PubMed ID: 32430207
    [TBL] [Abstract][Full Text] [Related]  

  • 4. Reduction in testing and change in testing algorithm associated with decrease in number of nosocomial Clostridioides (Clostridium) difficile infections.
    Cook PP; Nichols S; Coogan M; Opera J; DeHart M
    Am J Infect Control; 2020 Sep; 48(9):1019-1022. PubMed ID: 32044135
    [TBL] [Abstract][Full Text] [Related]  

  • 5. Clostridioides difficile infection in Africa: A narrative review.
    Kullin B; Abratt VR; Reid SJ; Riley TV
    Anaerobe; 2022 Apr; 74():102549. PubMed ID: 35337974
    [TBL] [Abstract][Full Text] [Related]  

  • 6. [Interpretation of group standard for
    Wu Y; Lu JX; Yan ZZ; Liu YX; Gu WP; Fu XQ; Xu YC; Wu AH; Huang HH; Zong ZY; Jin DZ; Zhao JH; Chen Y; Liu WP; Li WG
    Zhonghua Liu Xing Bing Xue Za Zhi; 2021 Jan; 42(1):64-67. PubMed ID: 33503698
    [TBL] [Abstract][Full Text] [Related]  

  • 7. Burden of Clostridioides difficile infection (CDI) - a systematic review of the epidemiology of primary and recurrent CDI.
    Finn E; Andersson FL; Madin-Warburton M
    BMC Infect Dis; 2021 May; 21(1):456. PubMed ID: 34016040
    [TBL] [Abstract][Full Text] [Related]  

  • 8. Effect of antibiotic to induce Clostridioides difficile-susceptibility and infectious strain in a mouse model of Clostridioides difficile infection and recurrence.
    Castro-Córdova P; Díaz-Yáñez F; Muñoz-Miralles J; Gil F; Paredes-Sabja D
    Anaerobe; 2020 Apr; 62():102149. PubMed ID: 31940467
    [TBL] [Abstract][Full Text] [Related]  

  • 9. Costs Associated with the Treatment of Clostridioides Difficile Infections.
    Sierocka A; Kiersnowska Z; Lemiech-Mirowska E; Marczak M
    Int J Environ Res Public Health; 2021 Jul; 18(14):. PubMed ID: 34300098
    [TBL] [Abstract][Full Text] [Related]  

  • 10. Clostridioides difficile epidemiology in India.
    Monaghan TM; Biswas R; Satav A; Ambalkar S; Kashyap RS
    Anaerobe; 2022 Apr; 74():102517. PubMed ID: 35063600
    [TBL] [Abstract][Full Text] [Related]  

  • 11. Diagnosis of Clostridium difficile infection: an ongoing conundrum for clinicians and for clinical laboratories.
    Burnham CA; Carroll KC
    Clin Microbiol Rev; 2013 Jul; 26(3):604-30. PubMed ID: 23824374
    [TBL] [Abstract][Full Text] [Related]  

  • 12. Ultrasensitive Clostridioides difficile Toxin Testing for Higher Diagnostic Accuracy.
    Sandlund J; Davies K; Wilcox MH
    J Clin Microbiol; 2020 May; 58(6):. PubMed ID: 32269098
    [TBL] [Abstract][Full Text] [Related]  

  • 13. Pediatric Clostridioides difficile Infection: Diagnosis and Diagnostic Stewardship.
    Schwenk HT; Pollock NR; Vaughan-Malloy AM
    J Pediatric Infect Dis Soc; 2021 Nov; 10(Supplement_3):S16-S21. PubMed ID: 34791395
    [TBL] [Abstract][Full Text] [Related]  

  • 14. Systemic Inflammatory Mediators Are Effective Biomarkers for Predicting Adverse Outcomes in Clostridioides difficile Infection.
    Dieterle MG; Putler R; Perry DA; Menon A; Abernathy-Close L; Perlman NS; Penkevich A; Standke A; Keidan M; Vendrov KC; Bergin IL; Young VB; Rao K
    mBio; 2020 May; 11(3):. PubMed ID: 32371595
    [No Abstract]   [Full Text] [Related]  

  • 15. Clostridioides difficile phage biology and application.
    Heuler J; Fortier LC; Sun X
    FEMS Microbiol Rev; 2021 Sep; 45(5):. PubMed ID: 33580957
    [TBL] [Abstract][Full Text] [Related]  

  • 16. The Laboratory Diagnosis of Clostridioides difficile Infection: An update of current laboratory practice.
    Somily AM; Khan MA; Morshed M
    J Infect Dev Ctries; 2021 Oct; 15(10):1364-1375. PubMed ID: 34780357
    [TBL] [Abstract][Full Text] [Related]  

  • 17. Treatment of Clostridioides difficile Infection and Non-compliance with Treatment Guidelines in Adults in 10 US Geographical Locations, 2013-2015.
    Novosad SA; Mu Y; Winston LG; Johnston H; Basiliere E; Olson DM; Farley MM; Revis A; Wilson L; Perlmutter R; Holzbauer SM; Whitten T; Phipps EC; Dumyati GK; Beldavs ZG; Ocampo VLS; Davis CM; Kainer M; Gerding DN; Guh AY
    J Gen Intern Med; 2020 Feb; 35(2):412-419. PubMed ID: 31768906
    [TBL] [Abstract][Full Text] [Related]  

  • 18. Reduced Clostridioides difficile infections in hospitalised older people through multiple quality improvement strategies.
    Dohrendorf CM; Unkel S; Scheithauer S; Kaase M; Meier V; Fenz D; Sasse J; Wappler M; Schweer-Herzig J; Friede T; Reichard U; Eiffert H; Nau R; Seele J
    Age Ageing; 2021 Nov; 50(6):2123-2132. PubMed ID: 34473822
    [TBL] [Abstract][Full Text] [Related]  

  • 19.
    Collins DA; Sohn KM; Wu Y; Ouchi K; Ishii Y; Elliott B; Riley TV; Tateda K;
    Emerg Microbes Infect; 2020; 9(1):42-52. PubMed ID: 31873046
    [No Abstract]   [Full Text] [Related]  

  • 20. Evaluation of a risk assessment model to predict infection with healthcare facility-onset Clostridioides difficile.
    Tilton CS; Sexton ME; Johnson SW; Gu C; Chen Z; Robichaux C; Metzger NL
    Am J Health Syst Pharm; 2021 Sep; 78(18):1681-1690. PubMed ID: 33954428
    [TBL] [Abstract][Full Text] [Related]  

    [Next]    [New Search]
    of 12.